Drug-induced cutaneous photosensitivity: Incidence, mechanism, prevention and management

Drug Safety

Volumn 25, Issue 5, 2002, Pages 345-372

  Moore, Douglas E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTI ACNE AGENT; ANTIINFECTIVE AGENT; ANTIOXIDANT; ARYLPROPIONIC ACID DERIVATIVE; BENZTHIAZIDE; CHLOROQUINE; CHLORPROMAZINE; CIPROFLOXACIN; DIURETIC AGENT; FUROSEMIDE; GRISEOFULVIN; HALOPERIDOL; HYDROCHLOROTHIAZIDE; LOCAL ANESTHETIC AGENT; MEFLOQUINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOTOSENSITIZING AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SULFONAMIDE; SULINDAC; SUNSCREEN; SUPROFEN; TETRACYCLINE DERIVATIVE; TIOTIXENE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; UNINDEXED DRUG;

CLINICAL FEATURE; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG RESPONSE; DRUG STRUCTURE; HUMAN; HYDROPHOBICITY; INCIDENCE; PHOTODERMATOSIS; PHOTOSENSITIVITY DISORDER; PREVENTION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RADIATION DOSE; REVIEW; SKIN MANIFESTATION; SOLAR RADIATION; SPECTACLES; SUNBURN; ULTRAVIOLET RADIATION;

EID: 0036279441     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225050-00004     Document Type: Review

References (114)

1. Solar and ultraviolet radiation
2. Epidemiology of non-melanoma skin cancer and solar keratoses in Australia: A tale of self-immolation in Elysian fields
3. Skin cancer detection and prevention: A community program promoting sun safe behaviours
4. Childhood sun exposure as a risk factor for melanoma: A systematic review of epidemiologic studies
5. Rickets
6. Photomedicine
7. Solar keratoses and their relationship to non-melanoma skin cancers
8. Ornithine decarboxylase: A key regulatory enzyme in normal and neoplastic growth
9. Biological UV-doses and the effect of an ozone layer depletion
10. Effect of column ozone on the variability of biologically effective UV radiation at high southern latitudes
11. Adverse drug reactions: Definitions, diagnosis and management
12. Photosensitivity
13. Phototoxicity and photoallergy
14. Photochemotherapy
15. The history of photodetection and photodynamic therapy
16. Novel therapeutic and diagnostic applications of hypocrellins and hypericins
17. Cutaneous photosensitivity diseases induced by exogenous agents
18. Phototoxicity associated with antipsychotics, antidepressants and anxiolytics
19. Photosensitivity associated with antibacterial agents
20. Photosensitivity reactions: A case report involving NSAIDs
21. Photosensitivity reaction associated with use of the combined oral contraceptive
22. Photobinding of chlorpromazine and its sulfoxide in vitro and in vivo
23. Involvement of singlet oxygen in the phototoxicity for a metabolite of piroxicam
24. Promotion of UV-induced skin carcinogenesis by azathioprine: Role of photochemical sensitization
25. Quinolone antibiotic with potential to photosensitise skin tumorigenesis
26. The carcinogenic risk of treatments for severe psoriasis
27. Cancer in dialysis and transplant patients
28. Amiodarone-induced photosensitivity and basal cell carcinoma
29. Basal cell carcinoma following amiodarone therapy
30. The interference of light in pharmacotherapy
31. Assessment of the phototoxicity risk of new drugs
32. Mechanisms of photosensitization by phototoxic drugs
33. Photosensitization
34. Photophysical and photochemical aspects of drug stability
35. Photodegradation of sulfamethoxazole: A chemical system capable of monitoring seasonal changes in UVB intensity
36. Photochemistry of chlorpromazine (2-chloro-N-(3-dimethylaminopropyl)phenothiazine) in propan-2-ol solution
37. Photolytic decomposition of hydrochlorothiazide
38. Photosensitization by antimalarial drugs
39. Photolytic degradation of frusemide
40. Photochemical studies on the anti-inflammatory drug diclofenac
41. Photodegradation of amiloride in aqueous solution
42. Photochemistry and photocyclization of aryl halides
43. Photochemistry of tetrachlorosalicylanilide and its relevance to the persistent light reactor
44. Photochemical decomposition of 1,4-benzodiazepines. Chlordiazepoxide
45. Systemic phototoxicity of drugs and other xenobiotics
46. Singlet molecular oxygen
47. Chemical reaction rates of amino acids with singlet oxygen
48. Oxidative damage to DNA: Formation, measurement and biological significance
49. Photoaddition to DNA by nonintercalated chlorpromazine molecules
50. Phototoxicity of non-steroidal anti-inflammatory drugs: Coincidence or specific mechanism?
51. New insights into the mode of action of anti-inflammatory drugs
52. A comparative study of the photochemistry of the non-steroidal anti-inflammatory drugs, naproxen, benoxaprofen and indomethacin
53. Molecular mechanism of naproxen photosensitization in red blood cells
54. New photodegradation pathways of naproxen, a phototoxic non-steroidal anti-inflammatory drug
55. Photochemical and photobiological properties of ketoprofen associated with the benzophenone chromophore
56. Photochemistry of 2-(3-benzoylphenyl)-propionic acid (ketoprofen). Pt 1. A picosecond and nanasecond time resolved study in aqueous solution
57. Photolytic degradation of ibuprofen: Toxicity of the isolated photoproducts on fibroblasts and erythrocytes
58. Molecular mechanism of drug photosensitization-II. Photohemolysis sensitized by ketoprofen
59. Time-resolved near infrared studies on singlet oxygen production by the photosensitizing 2-arylpropionic acids
60. Photobinding of tiaprofenic acid and suprofen to proteins and cells
61. Comparison of the DNA damage photoinduced by fenofibrate and ketoprofen, two phototoxic drugs of parent structure
62. Electron transfer processes in the reactivity of nonsteroidal anti-inflammatory drugs in the ground and excited states
63. An expanded profile of cutaneous reactions to non-steroidal anti-inflammatory drugs
64. Photochemical and photophysical properties of piroxicam and benoxaprofen in various solvents
65. Photodegradation of piroxicam under aerobic conditions: The photochemical keys of the piroxicam enigma?
66. Propionic acid-derived non-steroidal anti-inflammatory drugs are phototoxic in vitro
67. In vivo phototoxicity of non-steroidal anti-inflammatory drugs evaluated by the mouse tail technique
68. Spectroscopic studies of cutaneous photosensitizing agents. XVIII. Indomethacin
69. Kinetics of indomethacin degradation
70. The photochemistry of indomethacin
71. Effect of indomethacin on alteration of ATPase-positive Langerhans cell density and cutaneous sunburn reaction induced by ultraviolet-B radiation
72. Photoprotective effect of topical indomethacin - An experimental study
73. Contact and photocontact dermatitis due to benzydamine hydrochloride
74. Photodermatitis from benzydamine
75. Contact dermatitis from benzydamine hydrochloride
76. Contact allergy to benzydamine
77. Photodermatitis from benzydamine cream
78. Occupational contact allergy to benzydamine hydrochloride
79. Allergic contact dermatitis from benzydamine with probable cross-reaction to indomethacin
80. A study of the photodegradation of benzydamine in pharmaceutical formulations
81. Electron transfer mechanisms in photosensitization by the anti-inflammatory drug benzydamine
82. Sulfasalazine intolerance: A retrospective survey of use in patients with chronic inflammatory bowel disease
83. Oxidation photosensitized by tetracyclines
84. Photo-oxidation of tetracycline - A differential pulse polarographic study
85. Fluoroquinolone photosensitization: A review of clinical and laboratory studies
86. Tolerability of fluoroquinolone antibiotics
87. Fluoroquinolone antimicrobials: Singlet oxygen, superoxide and phototoxicity
88. Lichenoid photoeruptions in human immunodeficiency virus infection
89. Photochemical decomposition of sulfamethoxazole
90. Degradation of trimethoprim
91. Photosensitizing activity of the antibacterial drugs sulfamethoxazole and trimethoprim
92. Photosensitization by drugs in surfactant solutions
93. In vitro photoperoxidation as an indicator of the potential phototoxicity of non-steroidal anti-inflammatory 2-arylpropionic acids
94. Contact photodermatitis
95. Contact sensitisation and photocontact sensitisation of sunscreening agents
96. Particulate sun blocks: General principals
97. Adverse cutaneous reactions to the sun
98. Protection against solar ultraviolet radiation
99. Differential protection by two sunscreens from UV radiation-induced immunosuppression
100. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice
101. Immunosuppression induced by acute solar-simulated ultraviolet exposure in humans: Prevention by a sunscreen with SPF 15 and high UVA protection
102. Antioxidant therapy: A new pharmacological approach in shock, inflammation and ischemia/reperfusion injury
103. Solar UV induced erythema in human skin and nuclear factor-κB-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract